{"component": "definition", "props": {"groups": [{"size": 7, "snippet_links": [{"key": "chemical-compound", "type": "definition", "offset": [8, 25]}, {"key": "parent-compound", "type": "definition", "offset": [67, 82]}, {"key": "partial-substitution", "type": "clause", "offset": [149, 169]}, {"key": "using-information", "type": "clause", "offset": [317, 334]}, {"key": "number-of", "type": "definition", "offset": [391, 400]}, {"key": "the-parent", "type": "definition", "offset": [561, 571]}, {"key": "in-order-to", "type": "clause", "offset": [581, 592]}], "snippet": "means a chemical compound that was (i) structurally derived from a parent compound in one or more steps from another by a process of modification or partial substitution of at least one component wherein at least one structural feature is retained at each process step or (ii) actually derived from a parent compound using information obtained from testing one or more parent compounds. The number of intermediate steps or compounds is not relevant to the classification of a compound as a Derivative Compound. A compound need not have structural similarity to the parent compound in order to be classified as a Derivative Compound.", "samples": [{"hash": "kdKejO5J5aV", "uri": "/contracts/kdKejO5J5aV#derivative-compound", "label": "Research and Development Agreement (Arqule Inc)", "score": 18.0, "published": true}, {"hash": "hy8dCGAAQ5y", "uri": "/contracts/hy8dCGAAQ5y#derivative-compound", "label": "Research and Development Agreement (Arqule Inc)", "score": 18.0, "published": true}], "hash": "53da9d0273d9b799517f149af233c64e", "id": 1}, {"size": 5, "snippet_links": [{"key": "in-the-performance", "type": "clause", "offset": [43, 61]}, {"key": "the-collaboration", "type": "clause", "offset": [65, 82]}, {"key": "each-case", "type": "definition", "offset": [87, 96]}, {"key": "lead-compounds", "type": "definition", "offset": [114, 128]}], "snippet": "means any compound derived by Pharmacopeia in the performance of the Collaboration, in each case from one or more Lead Compounds, and having activity against the same Target as such Lead Compound(s). As used herein, a compound shall be deemed to have been \u201cderived from\u201d a Lead Compound if it *", "samples": [{"hash": "kuAPiXMERk0", "uri": "/contracts/kuAPiXMERk0#derivative-compound", "label": "Collaboration and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "fkc9bftpxIp", "uri": "/contracts/fkc9bftpxIp#derivative-compound", "label": "Collaboration and License Agreement (Ligand Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "NLxlZ5c7Pe", "uri": "/contracts/NLxlZ5c7Pe#derivative-compound", "label": "Collaboration and License Agreement (Ligand Pharmaceuticals Inc)", "score": 21.0, "published": true}], "hash": "b9cbfedc469f32df4a68887b3690a775", "id": 2}, {"size": 4, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "library-compound", "type": "definition", "offset": [34, 50]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [80, 98]}, {"key": "confidential-information", "type": "definition", "offset": [334, 358]}], "snippet": "means, with respect to a Cephalon Library Compound, a compound that was derived by or on behalf of Ambit from such Cephalon Library Compound (whether from the Cephalon Library Compound or from a predecessor compound that is derived from a Cephalon Library Compound), or derived or synthesized by or on behalf of Ambit from Cephalon\u2019s Confidential Information covering the structure or identity of the Cephalon Library Compound.", "samples": [{"hash": "fpEwgO23ZgS", "uri": "/contracts/fpEwgO23ZgS#derivative-compound", "label": "Collaboration Agreement (Ignyta, Inc.)", "score": 26.3552360535, "published": true}, {"hash": "e3SlsGPyaFK", "uri": "/contracts/e3SlsGPyaFK#derivative-compound", "label": "Collaboration Agreement (Ambit Biosciences Corp)", "score": 24.2361392975, "published": true}, {"hash": "cdgtbWnsvw5", "uri": "/contracts/cdgtbWnsvw5#derivative-compound", "label": "Collaboration Agreement (Ambit Biosciences Corp)", "score": 23.967830658, "published": true}], "hash": "58b1d654bc2f10c47d1ce9a6f16d2141", "id": 3}, {"size": 4, "snippet_links": [{"key": "by-or-on-behalf-of", "type": "definition", "offset": [78, 96]}, {"key": "in-performance", "type": "clause", "offset": [124, 138]}, {"key": "pursuant-to-section", "type": "clause", "offset": [175, 194]}, {"key": "chemical-modification", "type": "definition", "offset": [417, 438]}, {"key": "chemical-synthesis", "type": "definition", "offset": [518, 536]}, {"key": "based-on", "type": "clause", "offset": [606, 614]}, {"key": "selected-compounds", "type": "clause", "offset": [665, 683]}, {"key": "lead-compounds", "type": "definition", "offset": [687, 701]}, {"key": "derivative-compounds", "type": "definition", "offset": [703, 723]}, {"key": "without-limitation", "type": "clause", "offset": [738, 756]}, {"key": "contained-in", "type": "definition", "offset": [772, 784]}], "snippet": "means a compound which is derived from a Selected Compound or a Lead Compound by or on behalf of Schering, or by NeoGenesis in performance of medicinal chemistry optimization pursuant to Section 2.2(b), and having activity against the same Target as such Selected Compound and/or Lead Compound. A compound will be deemed to have been \"derived\" from a Selected Compound or a Lead Compound if it (i) is the result of a chemical modification made to a Selected Compound or Lead Compound, (ii) is otherwise derived from a chemical synthesis program based upon a Selected Compound or Lead Compound, or (iii) is based on proprietary structure-function data obtained from Selected Compounds or Lead Compounds. Derivative Compounds will include, without limitation, all Compounds contained in the NeoMorph Focused Library(ies).", "samples": [{"hash": "hY4GwfTQfsU", "uri": "/contracts/hY4GwfTQfsU#derivative-compound", "label": "Screening and Analysis Services Agreement (Neogenesis Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "e9ylXQju5Nm", "uri": "/contracts/e9ylXQju5Nm#derivative-compound", "label": "Confidentiality Agreement (Neogenesis Pharmaceuticals Inc)", "score": 18.0, "published": true}], "hash": "2c81c433f5aa9ee0e8c4df87382dc808", "id": 4}, {"size": 4, "snippet_links": [{"key": "chemical-compound", "type": "definition", "offset": [8, 25]}, {"key": "information-provided", "type": "clause", "offset": [216, 236]}, {"key": "partial-substitution", "type": "clause", "offset": [251, 271]}, {"key": "number-of", "type": "definition", "offset": [376, 385]}, {"key": "in-order-to", "type": "clause", "offset": [586, 597]}], "snippet": "means a chemical compound structurally derived in one or more steps from a Compound or another Derivative Compound by a process of modification (either through manipulation of a compound or synthesis from structural information provided hereunder) or partial substitution of at least one component wherein at least one structural feature is retained at each process step. The number of intermediate steps or compounds is not relevant to the classification of a compound as a Derivative Compound. A compound need not have structural similarity to another Compound or Derivative Compound in order to be classified as a Derivative Compound.", "samples": [{"hash": "gO6Kr9yP0U4", "uri": "/contracts/gO6Kr9yP0U4#derivative-compound", "label": "Compound Testing and Development Agreement (Scriptgen Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "e71FHzrFVm7", "uri": "/contracts/e71FHzrFVm7#derivative-compound", "label": "Compound Testing and Development Agreement (Scriptgen Pharmaceuticals Inc)", "score": 18.0, "published": true}], "hash": "b51af9706470757e2c9e1e0a09b75242", "id": 5}, {"size": 3, "snippet_links": [{"key": "licensed-compound", "type": "definition", "offset": [37, 54]}, {"key": "for-clarity", "type": "clause", "offset": [56, 67]}], "snippet": "means an analog or derivative of the Licensed Compound. For clarity, a Derivative Compound is not an Improvement.", "samples": [{"hash": "kIV4DpdBExh", "uri": "/contracts/kIV4DpdBExh#derivative-compound", "label": "License Agreement (GPC Biotech Ag)", "score": 21.0, "published": true}, {"hash": "e6iP0sJNWJN", "uri": "/contracts/e6iP0sJNWJN#derivative-compound", "label": "Co Development and License Agreement (GPC Biotech Ag)", "score": 21.0, "published": true}, {"hash": "3GRCch77mvX", "uri": "/contracts/3GRCch77mvX#derivative-compound", "label": "Co Development and License Agreement (Pharmion Corp)", "score": 21.0, "published": true}], "hash": "30e1301ed6321841bd4d83cf532b7c7b", "id": 6}, {"size": 3, "snippet_links": [{"key": "by-atmi", "type": "clause", "offset": [66, 73]}, {"key": "reliance-on", "type": "clause", "offset": [116, 127]}, {"key": "alliance-technology", "type": "definition", "offset": [128, 147]}, {"key": "independent-ip", "type": "clause", "offset": [154, 168]}, {"key": "the-alliance", "type": "clause", "offset": [215, 227]}], "snippet": "shall not include any compound or mixture developed independently by ATMI or its Affiliates or sublicensees without reliance on Alliance Technology or IM Independent IP, and that does not infringe or misappropriate the Alliance Technology or IM Independent IP.", "samples": [{"hash": "eV2zJqEMiUM", "uri": "/contracts/eV2zJqEMiUM#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.8151950836, "published": true}, {"hash": "lblBsO3oCrh", "uri": "/contracts/lblBsO3oCrh#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.7440109253, "published": true}, {"hash": "LpSyiOHXED", "uri": "/contracts/LpSyiOHXED#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.5715255737, "published": true}], "hash": "06df4a531b16b9f2b9d6059885d3d9fa", "id": 7}, {"size": 3, "snippet_links": [{"key": "cdp-field", "type": "definition", "offset": [53, 62]}, {"key": "by-the-parties", "type": "clause", "offset": [206, 220]}, {"key": "development-efforts", "type": "clause", "offset": [250, 269]}, {"key": "by-atmi", "type": "clause", "offset": [321, 328]}, {"key": "in-accordance-with", "type": "clause", "offset": [390, 408]}, {"key": "granted-to", "type": "clause", "offset": [422, 432]}, {"key": "used-in-this-agreement", "type": "clause", "offset": [457, 479]}, {"key": "based-on", "type": "clause", "offset": [588, 596]}, {"key": "hpc-technology", "type": "definition", "offset": [632, 646]}, {"key": "alliance-technology", "type": "definition", "offset": [648, 667]}, {"key": "independent-ip", "type": "clause", "offset": [675, 689]}, {"key": "related-to", "type": "clause", "offset": [707, 717]}, {"key": "for-the-purpose-of-this", "type": "clause", "offset": [735, 758]}, {"key": "modifications-to", "type": "clause", "offset": [814, 830]}, {"key": "atmi-independent-technology", "type": "definition", "offset": [922, 949]}, {"key": "performance-data", "type": "definition", "offset": [1093, 1109]}, {"key": "relating-to", "type": "definition", "offset": [1110, 1121]}, {"key": "lead-compounds", "type": "definition", "offset": [1134, 1148]}, {"key": "derivative-compounds", "type": "definition", "offset": [1150, 1170]}, {"key": "pursuant-to-a", "type": "definition", "offset": [1276, 1289]}, {"key": "reliance-on", "type": "clause", "offset": [1452, 1463]}, {"key": "the-alliance", "type": "clause", "offset": [1551, 1563]}], "snippet": "means any compound or mixture for application in the CDP Field that is made or derived from a Lead Compound and that is within the parameters or specifications defined in a specific Technology Firewall Set by the parties pursuant to their respective development efforts under a CDP, or as permitted to be made or derived by ATMI or under authority of ATMI or its Affiliates or Sublicensees in accordance with the licenses granted to ATMI under that CDP. As used in this Agreement, a compound or mixture shall be deemed to have been \u201cderived from\u201d a Lead Compound if it results from a CDP based on a Lead Compound or from the use of HPC Technology, Alliance Technology, or IM Independent IP, or is otherwise related to a Lead Compound. For the purpose of this definition, \u201cotherwise related\u201d shall mean any further modifications to a Lead Compound or Derivative Compound outside of this Agreement, but not modifications to ATMI Independent Technology created independently of any use of HPC Technology, Alliance Technology or IM Independent IP, including any compound based on structure and/or performance data relating to one or more Lead Compounds. Derivative Compounds shall also include a compound that is synthesized, based on, or derived from another Derivative Compound pursuant to a CDP as described above. \u201cDerivative Compound\u201d shall not include any compound or mixture developed independently by ATMI or its Affiliates or sublicensees without reliance on Alliance Technology or IM Independent IP, and that does not infringe or misappropriate the Alliance Technology or IM Independent IP.", "samples": [{"hash": "eV2zJqEMiUM", "uri": "/contracts/eV2zJqEMiUM#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.8151950836, "published": true}, {"hash": "lblBsO3oCrh", "uri": "/contracts/lblBsO3oCrh#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.7440109253, "published": true}, {"hash": "LpSyiOHXED", "uri": "/contracts/LpSyiOHXED#derivative-compound", "label": "Alliance Agreement (Intermolecular Inc)", "score": 22.5715255737, "published": true}], "hash": "13ebec3333d4d3bdda94c2ae20f81e04", "id": 8}, {"size": 3, "snippet_links": [{"key": "research-term", "type": "definition", "offset": [59, 72]}, {"key": "following-the", "type": "definition", "offset": [93, 106]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [133, 151]}, {"key": "in-performance", "type": "clause", "offset": [172, 186]}, {"key": "chemical-modification", "type": "definition", "offset": [333, 354]}], "snippet": "means a compound which is derived from a Compound during a Research Term or the [***] period following the end of such Research Term by or on behalf of Roche, or by lcagen in performance of medicinal chemistry optimization directed [***]. A compound will be deemed to have been \u201cderived\u201d from a Compound if it (i) is the result of a chemical modification made to a Compound, (ii) [***], or (iii) [***]. However, a compound is not a Derivative Compound (a) [***], or (b) [***].", "samples": [{"hash": "1uABdiLQPO", "uri": "/contracts/1uABdiLQPO#derivative-compound", "label": "License Agreement (Avista Public Acquisition Corp. II)", "score": 33.5639953613, "published": true}, {"hash": "3xT0izBErYw", "uri": "/contracts/3xT0izBErYw#derivative-compound", "label": "License Agreement (OmniAb, Inc.)", "score": 33.3203277588, "published": true}], "hash": "2845d1c439ff86f920221bf7e5c5be2b", "id": 9}, {"size": 3, "snippet_links": [{"key": "based-on", "type": "clause", "offset": [39, 47]}], "snippet": "also includes any compound synthesized based on, or derived from, another Derivative Compound in any way set forth in subsections (i), (ii) or (iii) above.", "samples": [{"hash": "dFn5th9ObHg", "uri": "/contracts/dFn5th9ObHg#derivative-compound", "label": "Collaboration and License Agreement (Pharmacopeia Inc)", "score": 18.0, "published": true}, {"hash": "bqlQkktWpG", "uri": "/contracts/bqlQkktWpG#derivative-compound", "label": "Collaboration and License Agreement (Pharmacopeia Inc)", "score": 18.0, "published": true}], "hash": "574769806950d84f7e91cfc345b872ee", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcZGVyaXZhdGl2ZS1jb21wb3VuZCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Derivative Compound", "size": 94, "snippet": "means a chemical compound that was (i) structurally derived from a parent compound in one or more steps from another by a process of modification or partial substitution of at least one component wherein at least one structural feature is retained at each process step or (ii) actually derived from a parent compound using information obtained from testing one or more parent compounds. The number of intermediate steps or compounds is not relevant to the classification of a compound as a Derivative Compound. A compound need not have structural similarity to the parent compound in order to be classified as a Derivative Compound.", "id": "derivative-compound", "examples": ["Milestone payments shall be payable only once with respect to a particular Optioned Lead Program, even though the Optioned Lead Program, Optioned Lead Program Compound, <strong>Derivative Compound</strong> or Drug Product may be subsequently developed for indications other than those for which Regulatory Approval was initially sought.", "In the event that an Optioned Lead Program Compound, <strong>Derivative Compound</strong> or Drug Product fails in development, any milestone payments previously paid with respect to such Optioned Lead Program Compound, <strong>Derivative Compound</strong> or Drug Product shall be fully creditable toward the same milestone due with respect to another Optioned Lead Program Compound, <strong>Derivative Compound</strong> or Drug Product included within the same Optioned Lead Program.", "Novartis shall make the following royalty payments to Infinity on total annual Net Sales of each Drug Product incorporating an Optioned Lead Program Compound or <strong>Derivative Compound</strong>, for which there is a Live Claim covering such Optioned Lead Program, or the related Optioned Lead Program Compounds, <strong>Derivative Compounds</strong> or Drug Products, or their uses or manufacture thereof on a country-by-country and Drug Product-by-Drug Product basis.", "Neither party may charge the services of its personnel or any third party to research or develop an Independent Compound, <strong>Derivative Compound</strong> thereof or Independent Product to the other party.", "Upon receipt of such approval from Cephalon, such <strong>Derivative Compound</strong> shall be deemed a Backup Compound, and the replaced Backup Compound shall no longer be a Licensed Compound.", "Ambit shall own all Licensed Compound IP related to any <strong>Derivative Compound</strong> that is covered solely by Ambit IP.", "If such Licensed Compound is covered by Ambit IP or Licensed Compound IP, Ambit agrees to grant, and hereby does grant, to Cephalon an exclusive, irrevocable, perpetual, worldwide, royalty-free, transferable and sublicenseable license under the Ambit IP and Ambit\u2019s rights in the Licensed Compound IP for the limited purpose of developing, making, having made, using, selling, offering to sell and importing such Licensed Compound or <strong>Derivative Compound</strong>.", "ArQule and Monsanto will jointly own any Patent Rights applied for or obtained by either Party covering any method of making or using any ArQule Compound, ArQule <strong>Derivative Compound</strong>, Monsanto Compound or Monsanto <strong>Derivative Compound</strong> where such method is invented jointly by Monsanto and ArQule.", "ArQule hereby grants Abbott a worldwide, royalty-free, irrevocable, exclusive license (with the right to sublicense) under any ArQule Patent Rights and Joint Patent Rights in or relating to any Abbott <strong>Derivative Compounds</strong> to make, have made, use, import, offer to sell, and sell any product that contains an Abbott <strong>Derivative Compound</strong>.", "Subject to the terms of Section 4.4.1, Pharmacopeia agrees to grant, and hereby grants to SPL an exclusive license under the Pharmacopeia Technology (exclusive even as to Pharmacopeia and its Affiliates) in the Territory, to make, have made, use, sell, offer to sell, import and export Agreement Products containing a Lead Compound which is a Hit or a corresponding <strong>Derivative Compound</strong> as an active ingredient."], "related": [["compound", "Compound", "Compound"], ["back-up-compound", "Back-Up Compound", "Back-Up Compound"], ["licensed-compound", "Licensed Compound", "Licensed Compound"], ["lead-compound", "Lead Compound", "Lead Compound"], ["derivative-product", "Derivative Product", "Derivative Product"]], "related_snippets": [], "updated": "2026-05-10T05:39:37+00:00"}, "json": true, "cursor": ""}}